342 related articles for article (PubMed ID: 10389286)
21. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
Hudita D; Posea C; Ceausu I; Rusu M
Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
[TBL] [Abstract][Full Text] [Related]
23. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
Lambrinoudaki IV; Christodoulakos GE; Panoulis CP; Rizos DA; Dendrinos SG; Liakakos T; Augoulea AD; Creatsas GC
Maturitas; 2004 Jun; 48(2):107-13. PubMed ID: 15172084
[TBL] [Abstract][Full Text] [Related]
24. Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women.
Ziaei S; Moaya M; Faghihzadeh S
Climacteric; 2010 Jun; 13(3):249-53. PubMed ID: 19848555
[TBL] [Abstract][Full Text] [Related]
25. Psychological effects of tibolone and sequential estrogen-progestogen therapy in perimenopausal women.
Inan I; Kelekci S; Yilmaz B
Gynecol Endocrinol; 2005 Feb; 20(2):64-7. PubMed ID: 15823823
[TBL] [Abstract][Full Text] [Related]
26. Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies.
Gallagher JC; Baylink DJ; Freeman R; McClung M
J Clin Endocrinol Metab; 2001 Oct; 86(10):4717-26. PubMed ID: 11600531
[TBL] [Abstract][Full Text] [Related]
27. Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison.
Pan HA; Wang ST; Pai MC; Chen CH; Wu MH; Huang KE
J Reprod Med; 2003 May; 48(5):375-80. PubMed ID: 12815913
[TBL] [Abstract][Full Text] [Related]
28. Comparison of two continuous combined estrogen progestogen regimens in postmenopausal women: a randomized trial.
AinMelk Y
Fertil Steril; 1996 Dec; 66(6):962-8. PubMed ID: 8941062
[TBL] [Abstract][Full Text] [Related]
29. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
Odmark IS; Carlström K; Jonsson B; Jonasson AF
Maturitas; 2006 Jan; 53(1):89-96. PubMed ID: 15964160
[TBL] [Abstract][Full Text] [Related]
30. Vaginal ultrasound of the endometrium in postmenopausal women with symptoms of urogenital atrophy on low-dose estrogen or tibolone treatment: a comparison.
Botsis D; Kassanos D; Kalogirou D; Antoniou G; Vitoratos N; Karakitsos P
Maturitas; 1997 Jan; 26(1):57-62. PubMed ID: 9032748
[TBL] [Abstract][Full Text] [Related]
31. Comparative effects on bone mineral density of tibolone, transdermal estrogen and oral estrogen/progestogen therapy in postmenopausal women.
Prelevic GM; Bartram C; Wood J; Okolo S; Ginsburg J
Gynecol Endocrinol; 1996 Dec; 10(6):413-20. PubMed ID: 9032569
[TBL] [Abstract][Full Text] [Related]
32. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
[TBL] [Abstract][Full Text] [Related]
33. Continuous combined hormone replacement therapy compared with tibolone.
Al-Azzawi F; Wahab M; Habiba M; Akkad A; Mason T
Obstet Gynecol; 1999 Feb; 93(2):258-64. PubMed ID: 9932566
[TBL] [Abstract][Full Text] [Related]
34. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
Bots ML; Evans GW; Riley W; McBride KH; Paskett ED; Helmond FA; Grobbee DE;
Eur Heart J; 2006 Mar; 27(6):746-55. PubMed ID: 16415304
[TBL] [Abstract][Full Text] [Related]
35. A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability.
Skouby SO; Sidelmann JJ; Nilas L; Jespersen J
Hum Reprod; 2007 Apr; 22(4):1186-91. PubMed ID: 17204528
[TBL] [Abstract][Full Text] [Related]
36. Effects of 8 years of treatment with tibolone 2.5 mg daily on postmenopausal bone loss.
Rymer J; Robinson J; Fogelman I
Osteoporos Int; 2001; 12(6):478-83. PubMed ID: 11446564
[TBL] [Abstract][Full Text] [Related]
37. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
[TBL] [Abstract][Full Text] [Related]
38. [Basic principles of hormone replacement therapy in the postmenopause].
Dören M
Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
[TBL] [Abstract][Full Text] [Related]
39. Oestrogen and cyclical progestogen in postmenopausal hormone replacement therapy.
MacLennan AH; MacLennan A; O'Neill S; Kirkgard Y; Wenzel S; Chambers HM
Med J Aust; 1992 Aug; 157(3):167-70. PubMed ID: 1321944
[TBL] [Abstract][Full Text] [Related]
40. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
Archer DF; Pickar JH; Bottiglioni F
Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
